← Azimuth Daily
Capturing data…
Capturing data…
FRI, 16 OCT · 86 ITEMS
"Optogenetic therapy shows early promise for treating retinitis pigmentosa" — Nature Medicine · Science & Medicine
This reports a new study in Nature Medicine showing that —using light-sensitive proteins to restore light sensitivity to retinal cells—has shown early positive results in patients with , a genetic eye disease that causes progressive vision loss. The therapy aims to restore some level of vision by making remaining retinal cells respond to light, even after the original photoreceptors have degenerated. Early promise likely means improved light perception or visual function in a small number of treated individuals.
The claim comes directly from a paper published in Nature Medicine, a highly reputable primary-source journal. The reporting sits close to the original data, so the claim itself is solid for what it says ('early promise'), though it does not indicate long-term efficacy or widespread applicability yet.
This is genuinely new, based on a just-published Nature Medicine study.